NRXP - NRX Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NRXP is currently covered by 4 analysts with an average price target of $30.5. This is a potential upside of $26.43 (797.06%) from yesterday's end of day stock price of $3.4.

NRX Pharmaceuticals's activity chart (see below) currently has 12 price targets and 28 ratings on display. The stock rating distribution of NRXP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.04% with an average time for these price targets to be met of 284.11 days.

Highest price target for NRXP is $40, Lowest price target is $10, average price target is $30.5.

Most recent stock forecast was given by THOMAS SHRADER from BTIG on 18-Aug-2026. First documented stock forecast 30-Jun-2022.

Best performing analysts who are covering NRXP - NRX Pharmaceuticals:

Vernon Bernardino Edward Woo Jason Kolbert Thomas Shrader Patrick Trucchio

Currently out of the existing stock ratings of NRXP, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Apr-2025

$10

$6.51 (186.53%)

$10

24 days ago
(18-Aug-2026)

0/5 (0%)

$6.56 (190.70%)

Buy Since 22-Aug-2025

$34

$30.27 (811.53%)

$34

4 months 6 days ago
(05-May-2026)

0/5 (0%)

$30.96 (1018.42%)

Buy Since 08-Sep-2025

$40

6 months 8 days ago
(03-Mar-2026)

1/2 (50%)

$37.16 (1308.45%)

769

Buy Since 09-Nov-2022

8 months 9 days ago
(02-Jan-2026)

2/2 (100%)

$-1.7 (-25.37%)

137

Buy Since 30-Jun-2022

$40

$36.27 (972.39%)

$19

10 months 26 days ago
(16-Oct-2025)

4/6 (66.67%)

$36.96 (1215.79%)

441

Show more analysts

Please expand the browser size to see the chart

What is NRXP (NRX Pharmaceuticals) average time for price targets to be met?

On average it took 284 days for the stock forecasts to be reached, with an average price target met ratio of 37.04%.

Which analyst most recently updated their price target on NRXP (NRX Pharmaceuticals)?

Thomas Shrader

Which analyst has the most public recommendations on NRXP (NRX Pharmaceuticals)?

Thomas Shrader works at BTIG and has 10 price targets and 9 ratings on NRXP

Which analyst is the currently most bullish on NRXP (NRX Pharmaceuticals)?

Vernon Bernardino with the highest potential upside of $36.51

Which analyst is the currently most reserved on NRXP (NRX Pharmaceuticals)?

Edward Woo with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?